• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

2D ultrasound measurement finds chance of early birth

Article

Measuring the fetal zone of the adrenal gland is a better predictor of preterm birth than measuring cervical length, according to research presented at the Society For Maternal-Fetal Medicine Feb. 4.

Measuring the fetal zone of the adrenal gland is a better predictor of preterm birth than measuring cervical length, according to research presented at the Society For Maternal-Fetal Medicine Feb. 4.

Three-D adrenal gland volume is a very accurate predictor of preterm birth, said Dr. Ozhan Turan, the study's lead author. However, most people in the world don't have access to 3D ultrasound technology, so the researchers created measurements that can be done with 2D ultrasound.

More than 60 patients who had preterm labor symptoms at 23 to 37 weeks gestation were studied. The researchers measured 3D adrenal gland volume and 2D depth of the whole gland, which they divided by the fetal zone. Preterm birth occurred at less than seven days after assessment for 20 women while 42 delivered seven days or more after assessment. Cervical length was similar in both groups, but adrenal gland volume (3D) and depth of the whole gland divided by fetal zone (2D) were higher in the first group, an indication that measuring the adrenal gland is effective in identifying the likelihood of preterm birth.

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2024 MJH Life Sciences

All rights reserved.